Page last updated: 2024-09-03

icrf 193 and Leukemia

icrf 193 has been researched along with Leukemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ando, J; Ando, M; Isobe, Y; Oshimi, K; Sasaki, M; Sugimoto, K; Suto, H; Tamayose, K; Tsutsui, M1

Other Studies

1 other study(ies) available for icrf 193 and Leukemia

ArticleYear
Hsp90-inhibitor geldanamycin abrogates G2 arrest in p53-negative leukemia cell lines through the depletion of Chk1.
    Oncogene, 2008, May-15, Volume: 27, Issue:22

    Topics: Antibiotics, Antineoplastic; Benzoquinones; Cell Death; Cell Line, Tumor; Cell Proliferation; Checkpoint Kinase 1; Diketopiperazines; DNA Damage; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drug Resistance, Neoplasm; G2 Phase; Genes, p53; HeLa Cells; HL-60 Cells; HSP90 Heat-Shock Proteins; Humans; Jurkat Cells; Lactams, Macrocyclic; Leukemia; Piperazines; Protein Kinases

2008